作者: Moshe Talpaz , Marc Bielski , EvanM. Hersh
DOI: 10.1007/BF00200175
关键词:
摘要: Low natural killer (NK) cell activity against the K-562 leukemia line was observed in patients with acute early stages of remission, i.e., 2–4 months (11.3%±7.95% specific target lysis). This parameter found to be normal among after a longer time remission (19.53%±7.55%) when compared healthy donors (18.46%±12.98%). A similar pattern studies antibody-dependent cell-mediated cytolysis (ADCC) CEM lymphoid tumor same group (37.58%±12.4% vs. 51%±6.79%